Whether you are switching from brand-name medications like Ozempic to Mounjaro or moving between compounded versions , the principles remain the same
Anecdotal evidence suggests that, by microdosing with GLP-1 medications, patients could unlock the longevity benefits of Semaglutide, like improved moods, reduced inflammation, better immunity, and reduced symptoms of chronic and autoimmune conditions
A stronger medication effect may also introduce new risks, side effects, or patient-selection concerns
Almost always yes, but confirm it and ask how care coordination works through the platform
In some cases, switching to a different medication with a different pharmacokinetic profile may be appropriate, as individual responses vary
The compound represents a paradigm shift from peptide-based to small-molecule incretin therapeutics